Perspectives: Added Structure

Abstract:In pharmaceutical research and development, only laboratories performing clinical safety studies are governed by the good laboratory practices (GLP) CFR Part 58. There are no other well-defined quality practices or standards existing for non-GLP laboratory research, including biomedical research that may lead to new drug discovery. But there needs to …

Access this article
Other ways to access this article
Please register to access this article

Social Bookmarking

Digg, delicious, NewsVine, Furl, Google, StumbleUpon, BlogMarks, Facebook

Featured advertisers